Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2007 3
2008 3
2009 4
2010 4
2011 7
2012 7
2013 13
2014 8
2015 11
2016 13
2017 7
2018 10
2019 4
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 21917849

85 results

Results by year

Filters applied: . Clear all
Page 1
Brain amyloid imaging.
Rowe CC, Villemagne VL. Rowe CC, et al. J Nucl Med. 2011 Nov;52(11):1733-40. doi: 10.2967/jnumed.110.076315. Epub 2011 Sep 14. J Nucl Med. 2011. PMID: 21917849 Free article.
Brain amyloid imaging.
Rowe CC, Villemagne VL. Rowe CC, et al. J Nucl Med Technol. 2013 Mar;41(1):11-8. doi: 10.2967/jnumed.110.076315. Epub 2013 Feb 8. J Nucl Med Technol. 2013. PMID: 23396994 Free article. Review.
Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection.
Ikonomovic MD, Buckley CJ, Heurling K, Sherwin P, Jones PA, Zanette M, Mathis CA, Klunk WE, Chakrabarty A, Ironside J, Ismail A, Smith C, Thal DR, Beach TG, Farrar G, Smith AP. Ikonomovic MD, et al. Acta Neuropathol Commun. 2016 Dec 12;4(1):130. doi: 10.1186/s40478-016-0399-z. Acta Neuropathol Commun. 2016. PMID: 27955679 Free PMC article. Clinical Trial.
Use of Flutemetamol F 18-Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment.
Wolk DA, Sadowsky C, Safirstein B, Rinne JO, Duara R, Perry R, Agronin M, Gamez J, Shi J, Ivanoiu A, Minthon L, Walker Z, Hasselbalch S, Holmes C, Sabbagh M, Albert M, Fleisher A, Loughlin P, Triau E, Frey K, Høgh P, Bozoki A, Bullock R, Salmon E, Farrar G, Buckley CJ, Zanette M, Sherwin PF, Cherubini A, Inglis F. Wolk DA, et al. JAMA Neurol. 2018 Sep 1;75(9):1114-1123. doi: 10.1001/jamaneurol.2018.0894. JAMA Neurol. 2018. PMID: 29799984 Free PMC article.
Amyloid PET in European and North American cohorts; and exploring age as a limit to clinical use of amyloid imaging.
Chiotis K, Carter SF, Farid K, Savitcheva I, Nordberg A; Diagnostic Molecular Imaging (DiMI) network and the Alzheimer’s Disease Neuroimaging Initiative. Chiotis K, et al. Eur J Nucl Med Mol Imaging. 2015 Sep;42(10):1492-506. doi: 10.1007/s00259-015-3115-5. Epub 2015 Jul 2. Eur J Nucl Med Mol Imaging. 2015. PMID: 26130168 Free PMC article.
85 results